ORD_16795/2024

Procedural & sub-applicationsDefault JudgmentsCourt of AppealDecision By Default—

Overview Decisions Citations Documents Timeline

Parties

Claimants

Abbott Laboratories(Abbott Group)
Abbott Diabetes Care Inc.(Abbott Group)
Abbott France(Abbott Group)
Abbott (S.V./N.V.)(Abbott Group)
Abbott B.V.(Abbott Group)
Abbott s.r.l.(Abbott Group)
Abbott Scandinavia Aktiebolag(Abbott Group)
Abbott GmbH(Abbott Group)
Abbott Diagnostics GmbH(Abbott Group)
Abbott Logistics B.V.(Abbott Group)

Reps: Christian Dekoninck; Patricia Cappuyns; François Pochart; Wim Maas; Dietrich Kamlah

Respondents

Dexcom Inc.(Dexcom Group)

Reps: Anne-Charlotte le Bihan; Laurent Labatte

Judges

Klaus GrabinskiPresident of the Court of Appeal

Patents

Outcome

Dismissed

Filed: —

First decided: Mar 14, 2024

Language: —

The President of the Court of Appeal declared the Abbott entities' appeal inadmissible from the outset because it was brought without leave to appeal as required under Rule 220.2 RoP, and noted that an inadmissible appeal cannot be withdrawn.